Patient-prosthesis mismatch following TAVR: time will tell

EuroIntervention 2023;19:707. DOI: 10.4244/EIJ-E-23-00048

Vinod Thourani
Vinod H. Thourani1, MD; Kimberly A. Holst1,2, MD
1. Department of Cardiovascular Surgery, Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA, USA; 2. Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA
In this issue of EuroIntervention, the team from the University of Bern in Switzerland present their assessment of patient-prosthesis mismatch (PPM) following transcatheter aortic valve replacement (TAVR) at their centre through a prospectively maintained registry of 2,463 patients1. Tomii and colleagues explored three distinct assessments of PPM in the study population: measured PPM on the discharge echocardiogram, predicted PPM by the effective orifice area of the implanted TAVR prosthesis, and predicted PPM by preprocedural cross-sectional imaging. As our understanding of PPM continues to grow, this report offers real-world insight into the prevalence and implications of PPM.

The authors describe the ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion

Latest news